National genomic SARS-CoV-2 surveillance programme
- Funded by Federal Office of Public Health (FOPH)
- Total publications:0 publications
Grant number: 48816
Grant search
Key facts
Disease
COVID-19Start & end year
2021Known Financial Commitments (USD)
$16,814,457.19Funder
Federal Office of Public Health (FOPH)Principal Investigator
Abteilung Übertragbare Krankheiten Sekretariat derResearch Location
SwitzerlandLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
Data Management and Data Sharing
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
During the COVID-19 pandemic, it was necessary to closely monitor the development and spread of circulating SARS-CoV-2 variants. Virus variants could influence the epidemiological situation by, for example, being more contagious, causing more severe illness, evading immunity after infection or vaccination, or affecting the efficacy of therapies. This grant enabled geographically and demographically representative genome sequencing of 2,000 samples per week. This project was coordinated by the National Reference Centre for Emerging Viral Infections (NAVI/CRIVE) at the University Hospital Graz (HUG). This monitoring allowed for a better assessment of the pandemic's development and also served as a basis for targeted adjustments to measures.